Virtual medical and behavioral healthcare provider MDLive has made it easier for patients to access telehealth services with the introduction of Sophie, a digital personal health assistant. An artificial intelligence-based chatbot that is part of MDLive's platform, Sophie guides patients through the registration process by first asking a series of questions to open an MDLive account. Next, Sophie walks patients through the steps to download the MDLive app. Once downloaded, the MDLive app helps patients determine whether scheduling a virtual or in-person visit with a healthcare professional is necessary.
London and Berlin-based, AI-powered health app maker Ada Health has raised $47 million (40 million euro) in a funding round led by global investment group Access Industries. June Fund, Cumberland VC, and entrepreneur William Tunstall-Pedoe also contributed along with existing investors. Ada Health officially launched its app back in April after a soft launch in late 2016 and six years of research and development. It asks relevant, personalized questions and suggests possible causes for users' symptoms. The company says more than 1.5 million people have used the app since March.
As hospitals and health systems leverage information technology, healthcare executives must advocate for caregivers to improve provider satisfaction, be prepared for a telehealth explosion, embrace machine learning and artificial intelligence, incorporate the Internet of Things, and prepare for more cyber-attacks, said Thomas Zenty, CEO of University Hospitals of Cleveland. Zenty delivered today's keynote address at Allscripts Client Experience, the EHR vendor's user conference here. The wellness of providers, the degree to which they are satisfied with their jobs, is key to operating a hospital or health system. "Physician satisfaction is at an all-time low," Zenty said. "The things we now have to do with our EHRs.
In our case, if you go into one of our simulations, you would learn how to lead a conversation in real life by having the ability to practice a similar conversation with a virtual, fully animated human that will respond to what you decide to say in the simulation that is coded with their own personality and memory and therefore mimicking real life behavior with you. Health is a very personal thing at the end of the day, and as much as we have a lot of technology being embedded into health with all the apps and all the telehealth platforms and everything around it, at the end of the day, because health is so personal, conversations remain the most powerful and most important element of driving positive health outcomes. We're much less defensive when it comes to any kind of feedback on our performance or approach, so virtual humans, when they are correctly designed, they are in some cases even more effective than a real person in certain types of conversation with real people. Now again, you have to have the virtual human designed correctly in terms of how they talk and how they move and how real or unreal they look on the screen, so I don't want to say all virtual humans are equal, because they're not.
Ada, a London and Berlin-based health tech startup, sees its official U.K. push today, and in doing so joins a number of other European startups attempting to market something akin to an AI-powered'doctor'. The company's mobile offering bills itself as a "personal health companion and telemedicine app" and via a conversational interface is designed to help you work out what symptoms you have and offer you information on what might be the cause. If needed, it then offers you a follow up remote consultation with a real doctor over text. In a call, two of Ada's founders -- CEO Daniel Nathrath and Chief Medical Officer Dr Claire Novorol -- explained that the app has been six years in the making, and actually started life out as being doctor-facing, helping clinicians to make better decisions. The same database and smart backend is now being offered to consumers to access, albeit with a much more consumer-friendly front-end.
What will the world look like 20 to 25 years from now? That's the question that investors in their forties should think about when considering which stocks to buy now. While even the best prognosticators can't know for sure what the future holds, three stocks seem to be pretty good bets to survive and thrive in the decades ahead. If you're in your forties, here's why Google's parent Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL), Illumina (NASDAQ:ILMN), and Teladoc (NYSE:TDOC) could be stocks to consider. Alphabet is about a lot more than just its enormously successful Google search engine. The company claims a leadership role in many of the most important technologies for the future, including artificial intelligence, robotics, and virtual reality.
In just the last six months, the company has announced major initiatives into healthcare including a partnership with clinical consultation provider Best Doctors to add Watson's cancer suite to employee benefits packages, a population health management alliance with Siemens Healthineers and an effort linking IBM's PowerAI deep learning software toolkit with NVIDIA's NVLink interconnect technology. And last month, Samsung waded into the digital health space via a partnership with American Well that leverages the Korean tech firm's consumer electronics with American Well's Exchange platform to enable providers and payers to connect and share telehealth services online. "Healthcare has been labeled as'ripe for disruption' for years, but the combination of government mandates and regulations, technological advancements and financial incentives of the last decade has seemed to finally get the needle moving," Derek Spearing, senior manager at Top Tier Consulting tells Healthcare Dive. Last May, the firm launched SAP Connected Health Platform, which leverages its SAP Hana in-memory computing platform with healthcare-specific components.
There are quite a few telemedicine startups to choose from these days including Doctor on Demand, HealthTap and even some of the older, more established companies like MDLive or American Well but Remedy is a new one we've just been turned onto promising high-quality doctors at a lower cost per visit with the use of what it refers to as artificial intelligence to help diagnose what ails you. Telemedicine is fast adopting the use of A.I. as an umbrella term in over-the-phone medical help. HealthTap just announced the launch of "Dr. AI," its own version of a smart search algorithm, and Remedy falls into this same category. But much of what is so-called artificial intelligence really depends on how you label what you consider AI.
The UK's National Health Service will soon begin a trial testing whether or not a chatbot can effectively replace a call center for non-emergency medical triage, according to a report from the Financial Times. Babylon, a UK-based telemedicine startup, will power the six-month trial in north-central London, which will include 1.2 million covered citizens. Babylon is a major telemedicine provider in its native England. The company's direct-to-consumer offering starts with an AI-powered chatbot which can escalate up to a video visit if necessary. Triage via Babylon requires about 12 text messages and takes about a minute and a half.